HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efstathios Kastritis Selected Research

Paraproteinemias (Monoclonal Gammopathy)

11/2022Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies.
1/2021Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance.
1/2021Overweight/Obesity and Monoclonal Gammopathy of Undetermined Significance.
12/2020Renal pathology in patients with monoclonal gammopathy or multiple myeloma: monoclonal immunoglobulins are not always the cause.
11/2020Monitoring Plasma Cell Dyscrasias With Cell-free DNA Analysis.
1/2020Cell-free DNA analysis for the detection of MYD88 and CXCR4 mutations in IgM monoclonal gammopathies; an update with clinicopathological correlations.
12/2018Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies.
11/2017The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
1/2017Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel.
4/2015Diagnosis of monoclonal gammopathy of renal significance.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Efstathios Kastritis Research Topics

Disease

91Multiple Myeloma
12/2022 - 11/2004
38Waldenstrom Macroglobulinemia (Macroglobulinemia)
11/2022 - 06/2007
36Immunoglobulin Light-chain Amyloidosis
07/2022 - 10/2007
35Neoplasms (Cancer)
11/2022 - 01/2005
19Amyloidosis
07/2022 - 01/2008
16Paraproteinemias (Monoclonal Gammopathy)
11/2022 - 12/2008
16COVID-19
02/2022 - 01/2020
12Bone Diseases (Bone Disease)
07/2021 - 03/2009
8Disease Progression
01/2022 - 03/2016
8Bone Resorption
11/2018 - 05/2006
7Monoclonal Gammopathy of Undetermined Significance
11/2022 - 06/2007
6Residual Neoplasm
12/2021 - 10/2019
6Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2018 - 01/2009
5Amyloid Plaque
08/2020 - 03/2015
5Peripheral Nervous System Diseases (PNS Diseases)
10/2019 - 04/2013
5Renal Insufficiency (Renal Failure)
05/2016 - 04/2007
4Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 03/2007
4Inflammation (Inflammations)
01/2022 - 02/2011
4Ovarian Neoplasms (Ovarian Cancer)
10/2021 - 01/2006
4Infections
01/2021 - 10/2019
4Osteonecrosis (Kienbock's Disease)
10/2017 - 12/2005
4Chromosome Aberrations (Chromosome Abnormalities)
01/2017 - 07/2012
4Cytopenia
01/2016 - 01/2009
4Carcinoma (Carcinomatosis)
01/2009 - 01/2006
3Thrombotic Microangiopathies
06/2022 - 01/2016
3Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2022 - 09/2021
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2022 - 03/2007
3Lymphoma (Lymphomas)
09/2021 - 12/2019
3B-Cell Lymphoma (Lymphoma, B Cell)
11/2020 - 06/2018
3POEMS Syndrome (Syndrome, POEMS)
01/2020 - 07/2006
3Plasmacytoma
01/2020 - 01/2018
3Hypercalcemia (Milk Alkali Syndrome)
01/2020 - 11/2017
3Cardiovascular Diseases (Cardiovascular Disease)
02/2017 - 03/2015
3Anemia
02/2017 - 07/2012
3Chronic Renal Insufficiency
06/2016 - 10/2013
3Pain (Aches)
01/2014 - 12/2008
3Fever (Fevers)
11/2010 - 06/2005

Drug/Important Bio-Agent (IBA)

39Bortezomib (Velcade)FDA Link
01/2022 - 04/2007
35Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 04/2007
26Lenalidomide (CC 5013)FDA Link
01/2022 - 03/2007
19Immunoglobulin M (IgM)IBA
11/2022 - 06/2007
13Biomarkers (Surrogate Marker)IBA
06/2022 - 07/2006
13Proteins (Proteins, Gene)FDA Link
03/2021 - 01/2007
12carfilzomibIBA
06/2022 - 01/2016
12Monoclonal AntibodiesIBA
01/2022 - 03/2009
11Proteasome InhibitorsIBA
06/2022 - 10/2007
11daratumumabIBA
06/2022 - 01/2018
11Amyloid (Amyloid Fibrils)IBA
01/2022 - 02/2010
11Rituximab (Mabthera)FDA Link
01/2022 - 09/2008
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 04/2007
10Thalidomide (Thalomid)FDA Link
01/2022 - 11/2004
10Immunoglobulins (Immunoglobulin)IBA
10/2021 - 12/2008
9VaccinesIBA
01/2022 - 01/2021
8BNT162 VaccineIBA
02/2022 - 01/2021
8Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2021 - 02/2010
8Diphosphonates (Bisphosphonates)IBA
01/2020 - 12/2005
7Neutralizing AntibodiesIBA
05/2022 - 01/2021
7Zoledronic Acid (Zometa)FDA Link
10/2017 - 12/2005
6Melphalan (Alkeran)FDA LinkGeneric
03/2022 - 10/2007
6PlatinumIBA
01/2020 - 01/2006
6L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2020 - 03/2009
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2012 - 01/2005
5AntibodiesIBA
02/2022 - 06/2016
5Pharmaceutical PreparationsIBA
12/2021 - 12/2007
5Angiopoietin-1IBA
10/2017 - 06/2007
5Angiopoietin-2IBA
10/2017 - 06/2007
5CytokinesIBA
11/2012 - 06/2007
4DNA (Deoxyribonucleic Acid)IBA
11/2022 - 12/2018
4Cell-Free Nucleic AcidsIBA
11/2022 - 12/2018
4ibrutinibIBA
01/2022 - 06/2018
4Prealbumin (Transthyretin)IBA
01/2022 - 01/2019
4Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 06/2005
4Immunomodulating AgentsIBA
10/2020 - 01/2013
4Cisplatin (Platino)FDA LinkGeneric
01/2020 - 01/2006
4Cystatin CIBA
01/2019 - 03/2009
4CreatinineIBA
01/2016 - 05/2008
4Pamidronate (Aredia)FDA LinkGeneric
10/2015 - 12/2005
4collagen type I trimeric cross-linked peptideIBA
01/2014 - 07/2006
4OsteoprotegerinIBA
01/2014 - 05/2006
4Alkaline PhosphataseIBA
01/2014 - 01/2007
4angiogeninIBA
11/2012 - 06/2007
3mRNA VaccinesIBA
01/2022 - 01/2021
3ixazomibIBA
01/2022 - 05/2020
3MicroRNAs (MicroRNA)IBA
01/2022 - 07/2021
3Nerve Growth Factor (NGF)IBA
12/2021 - 12/2019
3ChAdOx1 nCoV-19IBA
11/2021 - 01/2021
3pomalidomideIBA
12/2019 - 01/2013
3Proteasome Endopeptidase Complex (Proteasome)IBA
12/2019 - 04/2013
3CalciumIBA
11/2018 - 06/2016
3Chemokine CCL3IBA
01/2018 - 05/2006
3RANK LigandIBA
01/2018 - 05/2006
3OsteocalcinIBA
01/2014 - 01/2007
3Collagen Type I (Type I Collagen)IBA
01/2014 - 07/2006
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2012 - 06/2007

Therapy/Procedure

68Therapeutics
12/2022 - 06/2005
17Drug Therapy (Chemotherapy)
07/2022 - 01/2005
5Stem Cell Transplantation
03/2022 - 10/2007
4Autologous Transplantation
08/2021 - 01/2009
3Salvage Therapy
12/2018 - 01/2009
3Aftercare (After-Treatment)
01/2017 - 12/2005